Green tea (GT) is a beverage derived from the unfermented leaves of Camellia sinensis, a plant native to Asia. Green tea extract is marketed as an antioxidant and dietary supplement to support cardiovascular, metabolic, cognitive, and cellular health. Data on the use of GT in oncology are controversial, mainly because of the risk of interference with anticancer drugs. To date, the use of GT is recommended as supportive treatment in most oncological diseases.
To cite this article
Focus on the use of Green Tea in cancer setting: between lights and shadows
Submission date: 19 May 2023
Revised on: 08 Jun 2023
Accepted on: 19 Jun 2023
Published online: 20 Jun 2023
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.